PatentCAM supports Big Pharma Co’s successful launch of multi-billion dollar drug.
In an effort to develop best-in-class new chemical entities, one of the world’s largest biopharma companies licensed the PatentCAM™ software for the R&D team to track and monitor competitive patent information in real time.
With patent expirations related to its franchise products on the horizon, the company needed to produce a new blockbuster drug in order to keep its share price from dropping.
Managing thousands of patents related to diverse targets and mechanisms of action while monitoring newly published patents using traditional patent search tools or Microsoft Excel was not a realistic solution.
The company licensed PatentCAM, a reliable software solution for managing, reviewing, and monitoring competitive patent information across a variety of categories.
First, IP Checkups identified, reviewed and summarized pertinent information for thousands of historical patents into relevant technology categories.
Next, IP Checkups delivered the information in PatentCAM for the entire R&D team. This provided a centralized repository to perform ongoing review, sorting, summarizing and commenting on relevant patents.
Finally, PatentCAM was updated twice per week as new patents published in worldwide authorities enabling the R&D team to stay on top of the most current competitor innovations.
IPC’s customer released its first approved product related to the project 5 years after deployment of PatentCAM. Several more product releases are making their way through clinical trials now.
- $20 billion estimated product revenues over the next several years
- The R&D team has expanded three-fold and the share price of the company has increased exponentially over the past eight years.